Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biol Ther. 2011 Aug 01; 12(3):229-38.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Benzenesulfonates
Camptothecin
Carcinoma, Hepatocellular
Cell Death
Cell Nucleus
Cytoplasm
Deoxycytidine
Doxorubicin
Drug Synergism
Etoposide
Female
Fluorouracil
Genes, p53
Humans
Liver Neoplasms
Mice
Microtubule-Associated Proteins
Myeloid Cell Leukemia Sequence 1 Protein
Niacinamide
Phenylurea Compounds
Proto-Oncogene Proteins c-bcl-2
Pyridines
Quinacrine
Receptors, TNF-Related Apoptosis-Inducing Ligand
RNA, Small Interfering
TNF-Related Apoptosis-Inducing Ligand
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
authors with profiles
Nathan Graeme Dolloff
Charles D. Smith